Thanks CJ, I doubt they are adding for no reason and I doubt RVT-801 with Myovant was just a single contract, since Roivant would have some say and the many nants involved under Roivant may also require Avid Bioservices
Has anyone else noticed Bamforth and Walsh - BODs both on with Ampersand Capital ( not too far from Oncologie )